Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Certara, Inc.

Certara, Inc. (CERT) Stock Overview

Explore Certara, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CERT●NASDAQ
HealthcareMedical - Healthcare Information Services
$7.51
$0.40(5.63%)
U.S. Market opens in 63h 27m

Certara, Inc. (CERT)

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio-78.71
EPS (TTM)$0.39
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$7.13
3 Months$2.98
1 Year Target$4.58

CERT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Certara, Inc. (NASDAQ: CERT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Certara, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CERT on the NASDAQ shows an RSI of 67.59, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $4.58 for the NASDAQ listing.

Key metrics behind Certara, Inc.'s NASDAQ-traded stock include a P/E ratio of -78.71 and a market capitalization of 1.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CERT on the NASDAQ.

Price Performance (NASDAQ: CERT)

1-Day Change
5.63%
5-Day Change
4.60%
1-Month Change
38.31%
3-Month Change
18.83%
6-Month Change
-24.90%
Year-to-Date (YTD) Change
-14.76%
1-Year Change
-31.60%
3-Year Change
-59.86%
5-Year Change
-71.71%
All-Time (Max) Change
-80.28%

Contact Information

https://www.certara.com
609 716 7900
4 Radnor Corporate Center, Radnor, PA, 08540

Company Facts

15,760 Employees
IPO DateDec 11, 2020
CountryUS
Actively Trading

Frequently Asked Questions